Free Trial

JPMorgan American (LON:JAM) Hits New 12-Month High - Should You Buy?

JPMorgan American logo with Financial Services background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan American reached a new 52-week high, trading as high as GBX 1,167.56 (last GBX 1,164.83) on volume of 563,907 shares.
  • The trust has a market cap of £1.94 billion and a P/E of 25.19; last quarter it reported EPS of GBX 10.41 and revenue of GBX 2,395 million, with a net margin of 89.8% and ROE of 4.28%.
  • The fund is a high-conviction US equities trust run by an experienced team and is noted for outperforming the benchmark, net of fees, over 3, 5 and 10 years.
  • MarketBeat previews the top five stocks to own by June 1st.

JPMorgan American (LON:JAM - Get Free Report) shares reached a new 52-week high on Tuesday . The company traded as high as GBX 1,167.56 and last traded at GBX 1,164.83, with a volume of 563907 shares. The stock had previously closed at GBX 1,164.09.

JPMorgan American Price Performance

The company has a debt-to-equity ratio of 5.33, a current ratio of 0.53 and a quick ratio of 1.45. The stock has a market cap of £1.94 billion, a P/E ratio of 25.19 and a beta of 0.75. The company's 50 day simple moving average is GBX 1,114.21 and its 200 day simple moving average is GBX 1,118.50.

JPMorgan American (LON:JAM - Get Free Report) last issued its earnings results on Wednesday, April 1st. The company reported GBX 10.41 EPS for the quarter. JPMorgan American had a net margin of 89.80% and a return on equity of 4.28%. The firm had revenue of GBX 2,395 million during the quarter.

About JPMorgan American

(Get Free Report)

US equities, hand-picked by experts Our flagship American trust offers a high conviction portfolio of both US value and growth stocks that represent the managers' best ideas, designed to outperform across market cycles. The managers' decades of US stock-picking experience underpin a track record of consistent performance and dividends. Key points: Excellence - outperforming the benchmark, net of fees over 3, 5 and 10 years. Expertise - deep in-house stock research Experience - long-standing and proven investment team.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in JPMorgan American Right Now?

Before you consider JPMorgan American, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan American wasn't on the list.

While JPMorgan American currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines